Effects of monoclonal anti-transferrin receptor antibodies on in vitro growth of human solid tumor cells
- PMID: 3828993
Effects of monoclonal anti-transferrin receptor antibodies on in vitro growth of human solid tumor cells
Abstract
To determine whether anti-transferrin (Tf) receptor monoclonal antibodies might be useful in treatment of human solid tumors, in vitro effects of immunoglobulin A (42/6) and immunoglobulin G (B3/25) anti-Tf receptor antibodies on human solid tumor growth were examined. In colony and liquid cultures containing 10% serum, B3/25 did not inhibit growth of melanoma or ovarian carcinoma cell lines. 42/6 caused modest dose-dependent inhibition in colony cultures (maximum inhibition approximately 50%), and slowed growth of melanoma, ovarian carcinoma and epidermoid carcinoma cells in liquid culture. Inhibition was more pronounced in low (1%) serum, and was abrogated by 200 micrograms/ml iron-saturated Tf or 50 microM ferric nitriloacetate. All cells displayed high affinity Tf receptors (4-20 X 10(4)/cell). Cells grown in 1% serum and epidermoid carcinoma cells displayed more receptors, and susceptibility to 42/6 inhibition appeared related to higher receptor number. After culture with anti-Tf receptor antibodies, solid tumor cells showed a 57-93% reduction in surface Tf-binding sites. Tf uptake by cells grown for 24 h in B3/25 was approximately 50% of control, but was reduced to less than 10% of control with 42/6. Immunofluorescence staining of melanoma and HL60 promyelocytic leukemia cells suggested greater heterogeneity of Tf receptor display on melanoma than on leukemia cells. Previous studies showed 42/6 completely blocked blood cell Tf internalization and is a potent inhibitor of hemopoietic cell growth. In contrast, in solid tumor cells, inhibition of Tf uptake and growth inhibition are subtotal. Solid tumor resistance to 42/6 may be due in part to greater heterogeneity of Tf receptor display by proliferating cells. However, responses to iron-saturated Tf and ferric nitriloacetate in the presence of 42/6 also differ in hemopoietic and solid tumor cells, suggesting possible differences in Tf processing or iron growth requirements.
Similar articles
-
Mechanisms of growth inhibition by anti-transferrin receptor monoclonal antibodies.Cancer Res. 1986 Apr;46(4 Pt 1):1759-63. Cancer Res. 1986. PMID: 3004704
-
Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: evidence for synergistic antiproliferative effects.Cancer Res. 1990 Oct 1;50(19):6295-301. Cancer Res. 1990. PMID: 2400993
-
Effects of all-trans retinoic acid and antireceptor antibodies on growth and programmed cell death of human myeloma cells.Clin Cancer Res. 1996 Feb;2(2):253-9. Clin Cancer Res. 1996. PMID: 9816167
-
The role of transferrin receptors in hemopoietic cell growth.Exp Hematol. 1990 May;18(4):360-5. Exp Hematol. 1990. PMID: 2182335 Review.
-
Structure and function of transferrin receptors and their relationship to cell growth.Biochem Soc Symp. 1986;51:117-29. Biochem Soc Symp. 1986. PMID: 3545211 Review.
Cited by
-
Potential for targeting head and neck squamous cell carcinoma with monoclonal antibody K984.Cancer Immunol Immunother. 1992;34(4):252-8. doi: 10.1007/BF01741793. Cancer Immunol Immunother. 1992. PMID: 1371426 Free PMC article.
-
Expression of the zinc finger gene EVI-1 in ovarian and other cancers.Br J Cancer. 1996 Nov;74(10):1518-25. doi: 10.1038/bjc.1996.583. Br J Cancer. 1996. PMID: 8932329 Free PMC article.
-
Antibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-cancer Agents.Front Immunol. 2021 Mar 17;12:607692. doi: 10.3389/fimmu.2021.607692. eCollection 2021. Front Immunol. 2021. PMID: 33815364 Free PMC article. Review.
-
Selective stimulation of prostatic carcinoma cell proliferation by transferrin.Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):6197-201. doi: 10.1073/pnas.89.13.6197. Proc Natl Acad Sci U S A. 1992. PMID: 1631108 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Miscellaneous